Antineoplastic Agents in Breast Cancers With Mutational Signatures

Dr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures.
Source: Medscape Oncology - Category: Cancer & Oncology Authors: Source Type: podcasts